IMDX
Insight Molecular Diagnostics Inc.
3.40$
-7.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,475.6% | -526.6% | -2,176.1% | -5,748.1% | -4,827.0% | -360.3% | -274.0% | -1,212.2% | -1,731.5% | -486.8% | -23,871.9% | -3,877.8% | -1,614.0% | |
| 98.7% | 99.3% | 190.3% | 313.5% | 295.7% | 37.9% | 23.0% | 107.9% | 227.3% | 49.4% | 1,971.9% | 278.2% | 146.7% | |
| 180.1% | 141.7% | 263.6% | 194.2% | 307.8% | 36.9% | 22.8% | 97.3% | 200.4% | 63.3% | 1,921.9% | 276.6% | 150.8% | |
| -347.5% | 26.3% | 579.0% | -1,133.7% | 139.1% | -78.0% | -48.8% | -92.3% | 638.8% | 227.2% | 4,050.0% | -685.4% | 234.0% | |
| 0.0% | 4.0% | 13.6% | 183.7% | 187.0% | 14.4% | 14.4% | 67.4% | 403.8% | 129.9% | 1,915.6% | 325.9% | 234.8% | |
| 26.6% | -302.1% | -13.6% | -183.7% | -75.7% | -14.1% | -14.4% | -67.4% | -403.8% | -129.9% | -1,915.6% | -325.9% | -234.8% | |
| – | – | 635.2% | -5,181.7% | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | – | – | |
| – | – | – | – | -74.8% | -5.5% | -4.6% | -22.0% | -46.2% | -15.8% | -446.9% | -63.6% | -35.6% | |
| 2,651.0% | -7.0% | -17.0% | 9,468.3% | -221.7% | 729.3% | 1,335.7% | -22.0% | -46.2% | -22.1% | 77,181.3% | -236.0% | 1,422.9% | |
| 1,201.9% | -835.7% | -2,189.8% | 3,536.5% | -5,124.3% | 354.8% | 1,047.4% | -1,301.5% | -2,221.9% | -624.1% | 51,931.3% | -4,446.4% | -412.9% | |
| -1,475.6% | -530.5% | -2,189.8% | -5,931.7% | -4,640.0% | -374.7% | -288.4% | -1,279.5% | -2,135.4% | -616.7% | -25,787.5% | -4,203.8% | -1,848.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.